Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: J Mol Endocrinol. 2014 Mar 6;52(2):181–189. doi: 10.1530/JME-13-0266

Figure 2.

Figure 2

Kaplan Meier survival analysis including poorly differentiated (PD) and oncocytic poorly differentiated (oPD) thyroid carcinomas: Relapse free survival is significantly reduced for miR-23b. Tumor specific survival is reduced for miR-150. Tests are log rank tests.